Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agent for the treatment of type 2 diabetes mellitus. They increase endogenous levels of incretin hormones, which stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and contribute to reducing postp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung-Ho, Yoo, Jung-Hwa, Lee, Woo Je, Park, Cheol-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069390/
https://www.ncbi.nlm.nih.gov/pubmed/27766241
http://dx.doi.org/10.4093/dmj.2016.40.5.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069390/
https://www.ncbi.nlm.nih.gov/pubmed/27766241
http://dx.doi.org/10.4093/dmj.2016.40.5.339

Ejemplares similares